2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole
C33H26F3N3O — CID 118710921
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole
2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole (PubChem CID 118710921) has the molecular formula C33H26F3N3O and a molecular weight of 537.59 g/mol. Its IUPAC name is 2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole.
Molecular Properties
| Compound Name | 2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole |
|---|---|
| PubChem CID | 118710921 |
| Molecular Formula | C33H26F3N3O |
| Molecular Weight | 537.59 g/mol |
| Exact Mass | 537.20 |
| IUPAC Name | 2-(4-methoxyphenyl)-1-methyl-7-(3-methylphenyl)-6-phenyl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole |
| SMILES | COc1ccc(-c2c(-c3ccc(C(F)(F)F)cc3)n3nc(-c4ccccc4)c(-c4cccc(C)c4)c3n2C)cc1 |
| InChI | InChI=1S/C33H26F3N3O/c1-21-8-7-11-25(20-21)28-29(22-9-5-4-6-10-22)37-39-31(24-12-16-26(17-13-24)33(34,35)36)30(38(2)32(28)39)23-14-18-27(40-3)19-15-23/h4-20H,1-3H3 |
| InChIKey | KUKJABWSZGCDFR-UHFFFAOYSA-N |
| XLogP | 8.68 |
| TPSA | 31.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.59 |
| LogP ≤ 5 | 8.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118710921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.